Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice

被引:37
|
作者
Jabs, WJ
Sedlmeyer, A
Ramassar, V
Hidalgo, LG
Urmson, J
Afrouzian, M
Zhu, LF
Halloran, PF [1 ]
机构
[1] Univ Alberta, Dept Med, Div Nephrol & Transplantat Immunol, Edmonton, AB, Canada
[2] Univ Luebeck Sch Med, Dept Internal Med 1, Lubeck, Germany
[3] Goethe Univ Frankfurt, Dept Nephrol, D-6000 Frankfurt, Germany
[4] Univ Calgary, Dept Lab Med, Calgary, AB, Canada
[5] Univ Alberta, Dept Surg, Edmonton, AB, Canada
关键词
alloantibody; arteritis; Banff lesions; graft rejection;
D O I
10.1046/j.1600-6135.2003.00269.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The natural history and pathogenesis of the pathologic lesions that define rejection of kidney transplants have not been well characterized. We studied the evolution of the pathology of rejection in mouse kidney allografts, using four strain combinations across full major histocompatibility complex (MHC) plus nonMHC disparities, to permit more general conclusions. Interstitial infiltrate, MHC induction, and venulitis appeared by day 5, peaked at day 7-10, then stabilized or regressed by day 21. In contrast, tubulitis, arteritis, and glomerulitis were absent or mild at days 5 and 7, but progressed through day 21, indicating separate regulation and homeostatic control of these lesions. Edema, hemorrhage, and necrosis also increased through day 21. All lesions were T-dependent, failing to develop in T-cell-deficient hosts. Allografts into immunoglobulin-deficient hosts manifested typical infiltration, MHC induction, and tubulitis at days 7 and 21, indicating that these lesions are alloantibody-independent. However at day 21 kidneys rejecting in immunoglobulin-deficient hosts showed decreased edema, arteritis, venulitis, and necrosis. Thus the three groups of lesions are: T-cell-mediated interstitial infiltration, MHC induction, and venulitis, which develops rapidly then stabilizes; slower but progressive T-cell-mediated tubulitis and arteritis; and late antibody-mediated endothelial injury, which contributes to late edema, arteritis, and venulitis.
引用
收藏
页码:1501 / 1509
页数:9
相关论文
共 50 条
  • [21] MECHANISMS OF ISLET ALLOGRAFT-REJECTION
    CHARLES, A
    NOBLE, S
    OWNBEY, J
    BROWN, G
    OBARR, P
    DIABETES, 1978, 27 : 440 - 440
  • [22] EFFECTOR MECHANISMS IN ALLOGRAFT-REJECTION
    MASON, DW
    MORRIS, PJ
    ANNUAL REVIEW OF IMMUNOLOGY, 1986, 4 : 119 - 145
  • [23] CELLULAR MECHANISMS OF ALLOGRAFT-REJECTION
    HUTCHINSON, IV
    CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (05) : 722 - 728
  • [24] New insights into mechanisms of allograft rejection
    Pattison, JM
    Krensky, AM
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 313 (05): : 257 - 263
  • [25] Immunological mechanisms of liver allograft rejection
    Trunecka, P
    IMMUNOLOGICAL DISEASES OF LIVER AND GUT, 2004, 135 : 122 - 127
  • [26] Immune mechanisms of corneal allograft rejection
    Niederkorn, Jerry Y.
    CURRENT EYE RESEARCH, 2007, 32 (12) : 1005 - 1016
  • [27] Mechanisms of Chronic Cardiac Allograft Rejection
    Costello, John P.
    Mohanakumar, Thalachallour
    Nath, Dilip S.
    TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (04): : 395 - 399
  • [28] THE INFLAMMATORY MECHANISMS OF ALLOGRAFT-REJECTION
    HAYRY, P
    VONWILLEBRAND, E
    PARTHENAIS, E
    NEMLANDER, A
    SOOTS, A
    LAUTENSCHLAGER, I
    ALFOLDY, P
    RENKONEN, R
    IMMUNOLOGICAL REVIEWS, 1984, 77 : 85 - 142
  • [29] Immune mechanisms of lung allograft rejection
    Snyder, Laurie D.
    Palmer, Scott M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (05) : 534 - 543
  • [30] KIDNEY ALLOGRAFT HISTOLOGIC EVOLUTION AFTER TREATMENT OF ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Joly, M.
    Olagne, J.
    Parissiadis, A.
    Vargas, G. Gautier
    Cognard, N.
    Muller, C.
    Perrin, P.
    Braun, L.
    Heibel, F.
    Essayidi, A.
    Moulin, B.
    Caillard, S.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 19 - 19